Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
platelet-rich plasma (Medical University of Silesia)
- Development stage
- Unknown
- Lead developer
- Medical University of Silesia
- Administration
- Intramuscular
01
Overview
Platelet-rich plasma (PRP) is an autologous biologic therapy consisting of a concentrated suspension of platelets derived from a patient's own peripheral blood. Developed for use in temporomandibular disorders (TMD) by researchers at the Medical University of Silesia, PRP is administered via intramuscular injection into the masseter and temporalis muscles. The therapeutic effect is mediated by the degranulation of alpha-granules within the platelets, which releases a variety of growth factors, including platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), and vascular endothelial growth factor (VEGF). These factors promote tissue healing, angiogenesis, and the modulation of inflammatory processes, thereby reducing myofascial pain and improving jaw function in patients with TMD.
- Other names
- PRPAutologous platelet-rich plasma
02
Targets
VEGFR (VEGFR family)PDGFR (PDGFR family)TGFBR (TGF-beta receptor)
Beyond the preview
Go deeper on platelet-rich plasma (Medical University of Silesia).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on platelet-rich plasma (Medical University of Silesia).